All Stories

  1. A Brief History of Ebolavirus Disease: Paving the Way Forward by Learning from the Previous Outbreaks
  2. Synthesis and Enhanced Cellular Uptake In Vitro of Anti-HER2 Multifunctional Gold Nanoparticles
  3. Current Advancements in Addressing Key Challenges of Therapeutic Antibody Design, Manufacture, and Formulation
  4. Monoclonal antibody therapy of solid tumors: clinical limitations and novel strategies to enhance treatment efficacy
  5. Preparation-free method can enable rapid surfactant screening during industrial processing of influenza vaccines
  6. Analysis of the interaction of para-sulfonatocalix[8]arene with free amino acids and a six residue segment of β-amyloid peptide as a potential treatment for Alzheimer’s disease
  7. Demonstration of In Vitro Host-Guest Complex Formation and Safety of para-Sulfonatocalix[8]arene as a Delivery Vehicle for Two Antibiotic Drugs
  8. Ionic liquids as biocompatible stabilizers of proteins
  9. Choline ionic liquid enhances the stability of Herceptin® (trastuzumab)
  10. Crimean–Congo Hemorrhagic Fever: A bibliometric assessment of the literature
  11. The state-of-play and future of antibody therapeutics
  12. Development of Effective Anticancer Drug Candidates against Breast and Colon Cancers
  13. Site-specific glycosylation profile of influenza A (H1N1) hemagglutinin through tandem mass spectrometry
  14. Poly (methyl vinyl ether-co-maleic acid) – Pectin based hydrogel-forming systems: Gel, film, and microneedles
  15. Palladium N-Heterocyclic Carbene Complexes: Synthesis from Benzimidazolium Salts and Catalytic Activity in Carbon-carbon Bond-forming Reactions
  16. New compounds based on a benzimidazole nucleus: synthesis, characterization and cytotoxic activity against breast and colon cancer cell lines
  17. Carbon-carbon bond formation catalyzed by PEPPSI Pd-NHC
  18. Nile Red fluorescence spectrum decomposition enables rapid screening of large protein aggregates in complex biopharmaceutical formulations like influenza vaccines
  19. Laboratory Scale Production and Purification of a Therapeutic Antibody
  20. Biobetters From an Integrated Computational/Experimental Approach
  21. Rational design of rabies vaccine formulation for enhanced stability
  22. The effect of deuterium oxide on the conformational stability and aggregation of bovine serum albumin
  23. Host-Guest Complexes of Carboxylated Pillar[ n ]arenes With Drugs
  24. Pd complexes as catalysts for Suzuki-Miyaura reaction
  25. In vitro cytotoxic activities of new silver and PEPPSI palladium N-heterocyclic carbene complexes derived from benzimidazolium salts
  26. Lack of a synergistic effect of arginine–glutamic acid on the physical stability of spray-dried bovine serum albumin
  27. BSA aggregation
  28. Benzimidazolium-based novel silver N-heterocyclic carbene complexes: synthesis, characterisation and in vitro antimicrobial activity
  29. ChemInform Abstract: N-Methylphthalimide-Substituted Benzimidazolium Salts and PEPPSI Pd-NHC Complexes: Synthesis, Characterization and Catalytic Activity in Carbon-Carbon Bond-Forming Reactions.
  30. Flu virus split ratio
  31. N-Methylphthalimide-substituted benzimidazolium salts and PEPPSI Pd–NHC complexes: synthesis, characterization and catalytic activity in carbon–carbon bond-forming reactions
  32. Mechanistic insights into protein aggregation and the development of rational approaches and predictive tools to stabilization of biopharmaceuticals
  33. A screening tool for therapeutic monoclonal antibodies: Identifying the most stable protein and its best formulation based on thioflavin T binding
  34. Stability of monoclonal antibodies
  35. Evaluation of a Non-Arrhenius Model for Therapeutic Monoclonal Antibody Aggregation
  36. Prediction of protein binding regions
  37. Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies
  38. Tryptophan-Tryptophan Energy Transfer and Classification of Tryptophan Residues in Proteins Using a Therapeutic Monoclonal Antibody as a Model
  39. Prediction of Aggregation Prone Regions of Therapeutic Proteins
  40. Design and Application of Antibody Cysteine Variants
  41. Dynamic Fluctuations of Protein-Carbohydrate Interactions Promote Protein Aggregation
  42. Predictive tools for stabilization of therapeutic proteins
  43. Aggregation-Prone Motifs in Human Immunoglobulin G
  44. Design of therapeutic proteins with enhanced stability
  45. Comparison of the ATP Binding Sites of Protein Kinases Using Conformationally Diverse Bisindolylmaleimides
  46. Energy Migration in Novel pH-Triggered Self-Assembled β-Sheet Ribbons
  47. Femtosecond Electron-Transfer Reactions in Mono- and Polynucleotides and in DNA